https://www.manilatimes.net/2026/07/01/tmt-newswire/globenewswire/can-fite-phase-2a-pancreatic-cancer-study-with-namodenoson-achieves-primary-safety-endpoint-and-demonstrates-durable-survival-outcomes-in-advanced-disease/2376607